Novanta Inc.
As of Oct 22, 2026, Novanta is in Stage 3, the topping phase, now in week 10 (since Aug 14, 2026). It closed at $136.66, 19.0% below its 52-week high and below its 200-day average, which is rising.
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United S… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is NOVT early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
NOVT among Scientific & Technical Instruments8th of 32 by relative strength
All 32 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | KEYS | Stage 2 · wk 4 | 93 | −11.8% |
| 2 | COHR | Stage 4 · wk 1 | 92 | −30.9% |
| 3 | MLAB | Stage 2 · wk 10 | 90 | −2.9% |
| 4 | VPG | Stage 4 · wk 3 | 85 | −24.5% |
| 5 | ITRN | Stage 4 · wk 2 | 83 | −2.9% |
| 6 | MKSI | Stage 4 · wk 3 | 82 | −25.4% |
| 7 | ST | Stage 3 · wk 11 | 74 | −2.0% |
| 8 | NOVT | Stage 3 · wk 10 | 71 | −5.4% |
Novanta: quick answers
What stage is Novanta in?
As of Oct 22, 2026, Novanta (NOVT) is in Stage 3, the topping phase. It entered Stage 3 on Aug 14, 2026 and is in week 10. What the four stages mean
Is Novanta in an uptrend?
Its uptrend has stalled. Novanta is in Stage 3, the topping phase that follows an advance. It trades 3.6% below its 200-day average, which is rising.
How far is Novanta from its 52-week high?
Novanta closed at $136.66 on Oct 22, 2026, 19.0% below its 52-week high of $168.75. Its 52-week low is $99.22.
How has Novanta performed over the past year?
As of Oct 22, 2026, Novanta is up 20.9% over the past year and up 23.0% so far in 2026.
Which sector and industry is Novanta in?
Novanta is in the Scientific & Technical Instruments industry, part of the Information Technology sector.
About this companyInformation Technology· Scientific & Technical Instruments
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.